Control Bionics has entered into a reseller agreement with DNR Wheels Pte Limited, a leading distributor in Singapore of mobility, homecare and rehabilitation equipment and technology. Read the Press Release.
The Kids+ Foundation provides specialist physiotherapy, occupational therapy and speech pathology services to kids in Australia, and their AAC and Tech Coordinator, Noah Callan, used the NeuroNode Trilogy and reviewed the system in a video.
The first question we often get is “how much is a Control Bionics device?” We understand why: our technology has three powerful access methods and
Control Bionics CTO, James Schorey, and Sales Director, Meagan Koeneman, talked to NPR’s Cool Science Radio about the technology behind the NeuroNode Trilogy, who benefits from these products, and the importance of communication at the human level.
Control Bionics CEO Rob Wong sat down with the podcast Fear and Greed this week to discuss how Control Bionics helps patients with some of the most debilitating conditions to communicate.
As a regular contributor of Biotech Daily, which provides news on ASX-listed biotechnology companies, Dr. Boreham’s Crucible provides analysis of the biotech sector in Australia. Last week Control Bionics was featured in an article on the site.
Rob Wong, CEO of Control Bionics, chats with Alan Kohler from Eureka Report to discuss the latest news from the newly ASX-listed business. ” …
Strategic Partnership Offers Customers More Access to Control Bionics’ Industry-Leading Trilogy Product Line. (Milford, OH and New South Wales, AU) – Control Bionics, a global assistive
Medtech company Control Bionics (ASX:CBL) will list on the ASX next week. The company’s EMG (electromyography)-based technology helps people with disabilities inhibiting communications to do so
USA
745 Center Street, Suite 303
Milford OH 45150
AUSTRALIA
171 Union Road, Suite G.03
Surrey Hills VIC 3127
CANADA
Bridges Canada
2123 McCowan Road
Scarborough, Ontario M1S 3Y6
©2012-2021 Control Bionics, Inc. All Rights Reserved
